Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02832219 |
Recruitment Status :
Completed
First Posted : July 14, 2016
Last Update Posted : July 14, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obesity | Dietary Supplement: Molecular hydrogen Dietary Supplement: Placebo | Phase 3 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 12 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Official Title: | Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity |
Study Start Date : | January 2016 |
Actual Primary Completion Date : | April 2016 |
Actual Study Completion Date : | May 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Molecular hydrogen
Molecular hydrogen, tablet, 2 g/day, 4 weeks
|
Dietary Supplement: Molecular hydrogen |
Placebo Comparator: Placebo
Cellulose, tablet, 2 g/day, 4 weeks
|
Dietary Supplement: Placebo |
- Body fat percentage change [ Time Frame: Baseline vs. four weeks ]Baseline vs. four weeks
- Serum insulin change in IU/mL [ Time Frame: Baseline vs. four weeks ]Baseline vs. four weeks
- Serum ghrelin change in IU/mL [ Time Frame: Baseline vs. four weeks ]Baseline vs. four weeks

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- age > 55 years
- body mass index > 25 kg/m2
Exclusion Criteria:
- no history of H2 supplementation within the 4 weeks before study commenced
- no major chronic diseases, as evaluated by pre-participation health screening and clinical chemistry

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02832219
Serbia | |
Center for Health, Exercise and Sport Sciences | |
Belgrade, Serbia, 11000 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Assoc. Prof. Sergej M. Ostojic, MD, PhD, Principal Investigator, Center for Health, Exercise and Sport Sciences, Serbia |
ClinicalTrials.gov Identifier: | NCT02832219 |
Other Study ID Numbers: |
16-AD |
First Posted: | July 14, 2016 Key Record Dates |
Last Update Posted: | July 14, 2016 |
Last Verified: | July 2016 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Overweight Molecular hydrogen Insulin |
Obesity Overnutrition Nutrition Disorders Overweight Body Weight |